6d
Zacks Investment Research on MSNBioSpin's Innovations to Support Bruker Shares, Macro Issues to AilBruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio ...
Welcome to Bruker BioSpin and the world's most comprehensive range of NMR and EPR spectroscopy and preclinical imaging research tools. The Bruker BioSpin Group of companies develop, manufacture ...
Bruker Biospin at $905.70 million, and Bruker Energy & Supercon Technologies (BEST) at $283 million. Bruker Corporation, with substantial insider buying recently, is positioned for significant ...
Image Credit: Bruker BioSpin - NMR, EPR and Imaging Touchscreen display of count rate evolution and MIP online reconstruction. Image Credit: Bruker BioSpin - NMR, EPR and Imaging Interactive ...
The new departmental EMX-Plus EPR spectrometer from the Bruker Biospin Corporation is equipped with a cryogen free VT system that allows the samples to be cooled down to temperatures as low as 4.5 K.
Equities researchers at Zacks Research lifted their FY2025 earnings per share estimates for shares of Bruker in a research ...
It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano ...
Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio transformation. Yet, the company’s operations face the wrath of excessive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results